| Drug Name | cabozantinib |
|---|---|
| Other Drug Names | NKTR-102 |
| Chemical Name | N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
| Formula | C28H24FN3O5 |
| Mol. Wt. | 501.5116 |
| CAS No. | 849217-68-1 |
| UNII | 1C39JW444G |
| Target-based Actions | Axl tyrosine kinase receptor inhibitor; Flt3 tyrosine kinase inhibitor; Hepatocyte growth factor antagonist; Kit tyrosine kinase inhibitor; MET tyrosine kinase receptor family inhibitor; RET tyrosine kinase receptor family inhibitor; VEGF receptor antagon |
| ATC Codes | L01XE26 |
| Highest Status | 2014年批准上市 |
| Originator Company | Exelixis, Inc. |
| Structure |
 |
Extended Information